Invention novelty:
This technology is a novel device. It can measure quantitative data, record spectral signature, and screen skin tissue for abnormalities. This hyperspectral video surveillance system can determine and assess the skin’s constitutive elements spatially and temporally, ultimately detecting abnormalities and the potential presence of malignancies.
Value Proposition:
Skin cancer is the most common form of cancer. In the United States in 2010, there were 68,130 cases of melanoma (Metamark Genetics, 2011). With earlier detection mechanisms, these cases could potentially decrease. The market is headed toward methods of non-invasive detection. This device provides that capability – allowing pigmentation changes to be assessed and detected through spectral signaling. By not requiring invasive biopsies, cancer screening methods might improve in both quality and accuracy.
Technical Details
Johns Hopkins researchers found a new device that utilizes hyperspectral imaging to extract information. Through providing distinctions between colors and wavelengths, the hyperspectral camera provides new opportunity for minimally-invasive diagnosis of skin malignancies. It exploits a physics-based model of light and spectral signatures to isolate and assess composition of skin in a comparative manner.
Looking for Partners:
To develop & commercialize the technology as a medical device that can provide accurate and painless skin screening assessments using novel detection methods and hyperspectral imaging.
Stage of Development: Preliminary
Data Availability: Preliminary
Publications: US Issued Patent US 8,761,476
